|
0
|
|
A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant Pseudomonas aeruginosa infections.
(journals.asm.org)
|
Collings H
…
Iodise T
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#infection
#meta-analysis
|
|
0
|
|
Beyond mecA: a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA.
(journals.asm.org)
|
Sassman M
…
Rosato AE
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#proteomics
#mutation
#regulation
|
|
0
|
|
In vitro PK/PD modeling and simulation to accurately assess the antimicrobial activity of tigecycline against Mycobacterium abscessus.
(journals.asm.org)
|
Park H
…
Meibohm B
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#amr
#infection
#pharmacodynamics
#susceptibility
|
|
0
|
|
Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to beta-lactam antibiotics.
(journals.asm.org)
|
Fingleton C
…
O'Gara JP
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#virulence
#metabolism
#infection
|
|
0
|
|
Co-selection of genetic antibiotic resistance in Streptococcus pneumoniae after repeated azithromycin mass drug administrations in Niger.
(journals.asm.org)
|
Hinterwirth A
…
Doan T
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#sequencing
#co-selection
#colonization
#antibiotic
|
|
0
|
|
Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain.
(journals.asm.org)
|
Llorente J
…
Yuste J
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#vaccination
#infection
#surveillance
#serotype
|
|
0
|
|
Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia.
(journals.asm.org)
|
Williamson R
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#infection
#amr
#modeling
|
|
0
|
|
Pharmacokinetics/pharmacodynamics of ceftazidime-avibactam in critically ill adult patients receiving continuous renal replacement therapy.
(journals.asm.org)
|
Li C
…
Ge Y
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#pharmacodynamics
#dosing
#amr
#sepsis
|
|
0
|
|
US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
(academic.oup.com)
|
Hiruy H
…
Farley JJ
Clinical Infectious Diseases
2026-02-04
|
#amr
#infection
#drug development
#pharmacodynamics
|
|
0
|
|
Essential role of MHC II in the antitubercular efficacy of pyrazinamide.
(journals.asm.org)
|
Lamont EA
…
Baughn AD
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#tb
#immunity
#infection
#amr
|
|
0
|
|
A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D2EFT Study.
(academic.oup.com)
|
Nyein PP
…
Matthews GV
Clinical Infectious Diseases
2026-02-04
|
#amr
#hiv
#clinical trial
#treatment
|
|
0
|
|
A Short, All-oral Regimen for Pre-extensively Drug-resistant Tuberculosis: A Multicenter Open-label Single-arm Study.
(academic.oup.com)
|
Li Y
…
Zhang W
Clinical Infectious Diseases
2026-02-04
|
#tb
#amr
#infection
#chemotherapy
|
|
0
|
|
Protective mechanism of action of the antifungal drug naftifine against Mycobacterium abscessus infection.
(journals.asm.org)
|
Wang J
…
Lee S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#autophagy
#infection
#sequencing
#amr
|
|
0
|
|
A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model.
(journals.asm.org)
|
Sordello S
…
Upton AM
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#pharmacodynamics
#amr
#tb
|
|
0
|
|
Monthly dalbavancin dosing for suppressive therapy: a pharmacokinetic estimation analysis and case series.
(journals.asm.org)
|
Kufel WD
…
Volk C
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#amr
#infection
#modeling
|
|
0
|
|
Clinical Manifestations, Long-Term Trends, and Risk Factors for Treatment Failure in Native Vertebral Osteomyelitis: A 26-Year Mayo Clinic Experience.
(academic.oup.com)
|
Matsuo T
…
Berbari EF
Clinical Infectious Diseases
2026-02-04
|
#osteomyelitis
#infection
#bacteremia
#amr
#epidemiology
|
|
0
|
|
Comparison of gradient concentration strip and EUCAST methods for itraconazole and posaconazole MICs in Trichophyton indotineae.
(journals.asm.org)
|
Tireau B
…
Delliere S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#antifungal
#susceptibility
#dermatophytosis
#amr
#phenotypic
|
|
0
|
|
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanisms.
(journals.asm.org)
|
Mahadevan R
…
Rao GG
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacodynamics
#amr
#modeling
#infection
|
|
0
|
|
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.
(journals.asm.org)
|
Leonard VHJ
…
Ganem D
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#antiviral
#influenza
#inhibitor
#amr
#protein-protein interaction
|
|
0
|
|
Epidemiologic and Bacterial Factors Facilitating Long-term Transmission of Multidrug-Resistant Tuberculosis in Shanghai, China.
(academic.oup.com)
|
Lu X
…
Yang C
Clinical Infectious Diseases
2026-02-04
|
#amr
#phylogenomics
#transmission
#sequencing
#tb
|
|
0
|
|
Antibacterial activity of enmetazobactam against Acinetobacter spp.: a molecular dissection of mechanism of action and resistance determinants.
(journals.asm.org)
|
Baez-Barroso G-A
…
Beceiro A
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#susceptibility
#infection
|
|
0
|
|
A short antimicrobial peptides family demonstrates efficacy to infection via a multimodal mechanism of action.
(journals.asm.org)
|
Liu Y
…
Ru S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#antimicrobial peptides
#biofilm
#amr
#sepsis
#virulence
|
|
0
|
|
Accurate plasmid reconstruction from metagenomics data using assembly-alignment graphs and contrastive learning.
(nature.com)
|
Piera Lindez P
…
Rasmussen S
Nature Biotechnology
2026-02-04
|
#metagenomics
#assembly
#plasmid
#amr
#binning
|
|
0
|
|
Diet and environmental factors jointly drive the gut microbiome, resistome, and virulome of urban bats.
(nature.com)
|
Huang L
…
Sun KP
npj Biofilms and Microbiomes
2026-02-04
|
#virulome
#microbiome
#metagenomics
#amr
|
|
0
|
|
Comparative Safety of Different Antibiotic Regimens for the Treatment of Outpatient Community-Acquired Pneumonia Among Otherwise Healthy Adults.
(academic.oup.com)
|
Butler AM
…
Durkin MJ
Clinical Infectious Diseases
2026-02-04
|
#safety
#infection
#amr
#pneumonia
|
|
0
|
|
Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era.
(academic.oup.com)
|
Churchyard GJ
…
Hesseling AC
Clinical Infectious Diseases
2026-02-04
|
#tb
#amr
#infection
#preventive
|
|
0
|
|
Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023-2025.
(journals.asm.org)
|
Omachi R
…
Maeda T
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#sequencing
#phylogenomics
#infection
#surveillance
|
|
0
|
|
fosZ, a novel plasmid-borne fosfomycin resistance gene in Pseudomonas species, especially carbapenem-resistant Pseudomonas aeruginosa isolates.
(journals.asm.org)
|
Shao Y
…
Guo Q
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#plasmid
#conjugation
|
|
0
|
|
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).
(journals.asm.org)
|
Bekker A
…
Cressey TR
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#sepsis
#neonatal
#amr
#modeling
|
|
0
|
|
Isobavachalcone effectively inhibits the growth of Candida albicans.
(journals.asm.org)
|
Xie P
…
Huang Y
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#antifungal
#virulence
#infection
#metabolism
|
|
0
|
|
The Impact of Lower Respiratory Tract Sample Cultures on Outcomes in Community-Acquired Pneumonia: A Propensity Score-Matched Cohort Study.
(academic.oup.com)
|
Fally M
…
Ravn P
Clinical Infectious Diseases
2026-02-04
|
#pneumonia
#culture
#amr
#infection
|
|
0
|
|
Long-term Outcomes Among People With Multidrug-Resistant Tuberculosis in Vietnam: A Prospective Cohort Study.
(academic.oup.com)
|
MacLean EL
…
Fox GJ
Clinical Infectious Diseases
2026-02-04
|
#tb
#amr
#cohort
#mortality
#infection
|
|
0
|
|
Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant Mycobacterium avium complex infection.
(journals.asm.org)
|
Park J
…
Shin SJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#tb
#amr
#infection
#macrophage
|
|
0
|
|
Phylogenetic diversification and fitness trade-offs of TetA variants in mediating eravacycline resistance in Klebsiella pneumoniae.
(journals.asm.org)
|
Fan M
…
Liu G
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#phylogenomics
#fitness
|
|
0
|
|
Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremia.
(journals.asm.org)
|
Shah S
…
Smith BJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#bacteremia
#infection
#amr
#endocarditis
|
|
0
|
|
Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.
(journals.asm.org)
|
Gumbo T
…
Srivastava S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#tb
#pharmacokinetics
#pharmacodynamics
#modeling
|
|
0
|
|
Pharmacokinetic-pharmacodynamic target attainment with continuous infusion piperacillin in patients admitted to the ICU with hospital-acquired pneumonia.
(journals.asm.org)
|
Zurawska M
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#infection
#modeling
#amr
#renal
|
|
0
|
|
NDM-63: a novel NDM metallo-beta-lactamase variant in the L3 loop, from a Klebsiella pneumoniae clinical isolate.
(journals.asm.org)
|
Boncompagni SR
…
Rossolini GM
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#plasmid
|
|
0
|
|
Gtr9 mutation trades phage resistance for carbapenem sensitivity to potentiate phage-meropenem therapy against carbapenem-resistant Acinetobacter baumannii in vitro.
(journals.asm.org)
|
Luo J
…
Luo C
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#phage
#amr
#synergy
#biofilm
#virulence
|
|
0
|
|
Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis.
(journals.asm.org)
|
Mohammad S
…
Almangour TA
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#amr
#infection
#meta-analysis
#treatment
|
|
0
|
|
An alveolar macrophage-targeted ciprofloxacin polymeric prodrug improves survival in a murine model of Klebsiella pneumoniae pneumonia.
(journals.asm.org)
|
Lopez CL
…
Stayton PS
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#drug delivery
#pneumonia
#amr
#nanomaterials
#inflammation
|